Aki Ishiyama
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis 30
- Alkaloids: synthesis and pharmacology 10
- Biotechnology top 2%
- Marine Sponges and Natural Products 14
- Toxicology top 5%
- Organic Chemistry top 5%
- Carbohydrate Chemistry and Synthesis 9
- Biochemistry top 5%
- Traditional and Medicinal Uses of Annonaceae 13
-
- Phytochemical compounds biological activities 16
-
- Malaria Research and Control 16
- Research on Leishmaniasis Studies 12
- Co-authors
- Kazuhiko OtoguroSatoshi ŌmuraMasato IwatsukiHaruki YamadaMiyuki NamatameKazuro ShiomiHiroaki KiyoharaYōko Takahashi
- Cited by
- PharmacologyBiotechnologyToxicology
In The Last Decade
Aki Ishiyama
81 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 100
- Pharmacology 641
- Biotechnology 319
- Toxicology 72
- Organic Chemistry 590
- Biochemistry 141
Countries citing papers authored by Aki Ishiyama
This map shows the geographic impact of Aki Ishiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aki Ishiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aki Ishiyama more than expected).
Fields of papers citing papers by Aki Ishiyama
This network shows the impact of papers produced by Aki Ishiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aki Ishiyama. The network helps show where Aki Ishiyama may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aki Ishiyama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 13 | |
| 3 | 2022 | 6 | |
| 4 | 2021 | 2 | |
| 5 | 2020 | 1 | |
| 6 | 2019 | 16 | |
| 7 | 2018 | 9 | |
| 8 | 2016 | 5 | |
| 9 | 2014 | 11 | |
| 10 | 2013 | 38 | |
| 11 | 2012 | 11 | |
| 12 | 2011 | 76 | |
| 13 | 2011 | 37 | |
| 14 | 2011 | 3 | |
| 15 | 2009 | 27 | |
| 16 | 2008 | 69 | |
| 17 | 2006 | 38 | |
| 18 | A morphable 3-D face model obtained from range images of faces and its application to face image synthesis | 2004 | 1 |
| 19 | 2001 | 88 | |
| 20 | 1999 | 16 |
About Aki Ishiyama
Aki Ishiyama is a scholar working on Pharmacology, Biotechnology and Biochemistry, having authored 86 papers that have together received 1.9k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (30 papers), Phytochemical compounds biological activities (16 papers), Malaria Research and Control (16 papers), Marine Sponges and Natural Products (14 papers), Traditional and Medicinal Uses of Annonaceae (13 papers), Research on Leishmaniasis Studies (12 papers), Alkaloids: synthesis and pharmacology (10 papers) and Carbohydrate Chemistry and Synthesis (9 papers). The work is most often cited by research in Pharmacology (641 citations), Biotechnology (319 citations) and Toxicology (72 citations). Aki Ishiyama has collaborated with scholars based in Japan, Egypt and Thailand. Frequent co-authors include Kazuhiko Otoguro, Satoshi Ōmura, Masato Iwatsuki, Haruki Yamada, Miyuki Namatame, Kazuro Shiomi, Hiroaki Kiyohara, Yōko Takahashi, Rei Hokari and Tomoyasu Hirose. Their work appears in journals such as Journal of the American Chemical Society, Scientific Reports and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.